| __timestamp | Amneal Pharmaceuticals, Inc. | Insmed Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 84615000 | 31073000 |
| Thursday, January 1, 2015 | 109679000 | 43216000 |
| Friday, January 1, 2016 | 118757000 | 50679000 |
| Sunday, January 1, 2017 | 109046000 | 79171000 |
| Monday, January 1, 2018 | 230435000 | 168218000 |
| Tuesday, January 1, 2019 | 289598000 | 210796000 |
| Wednesday, January 1, 2020 | 326727000 | 203613000 |
| Friday, January 1, 2021 | 365504000 | 234273000 |
| Saturday, January 1, 2022 | 399700000 | 265784000 |
| Sunday, January 1, 2023 | 429675000 | 344501000 |
Unleashing insights
In the competitive landscape of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. Over the past decade, Insmed Incorporated and Amneal Pharmaceuticals, Inc. have shown distinct strategies in optimizing these costs.
From 2014 to 2023, Amneal Pharmaceuticals, Inc. consistently reported higher SG&A expenses, peaking at approximately 430 million in 2023. This represents a staggering 407% increase from their 2014 figures. In contrast, Insmed Incorporated, while also experiencing growth, maintained a more moderate increase of around 1,009% over the same period, reaching about 345 million in 2023.
The data suggests that while both companies have expanded their operations, Insmed's approach to SG&A cost management appears more restrained. This could indicate a strategic focus on efficiency, potentially offering them a competitive edge in the long run.
AstraZeneca PLC and Amneal Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Novartis AG vs Insmed Incorporated Trends and Insights
Biogen Inc. and Amneal Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Who Optimizes SG&A Costs Better? Insmed Incorporated or Xenon Pharmaceuticals Inc.
Cost Management Insights: SG&A Expenses for Insmed Incorporated and Vericel Corporation
Who Optimizes SG&A Costs Better? Insmed Incorporated or Supernus Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Insmed Incorporated and Iovance Biotherapeutics, Inc.
Comparing SG&A Expenses: Amneal Pharmaceuticals, Inc. vs Viking Therapeutics, Inc. Trends and Insights
Selling, General, and Administrative Costs: Amneal Pharmaceuticals, Inc. vs Xenon Pharmaceuticals Inc.
Operational Costs Compared: SG&A Analysis of Amneal Pharmaceuticals, Inc. and PTC Therapeutics, Inc.
Comparing SG&A Expenses: Amneal Pharmaceuticals, Inc. vs Arrowhead Pharmaceuticals, Inc. Trends and Insights
Who Optimizes SG&A Costs Better? Amneal Pharmaceuticals, Inc. or Iovance Biotherapeutics, Inc.